Alembic Pharma cancer drug Erlotinib gets USFDA okay Ruchika Sharma9 July 2021 12:16 PM ISTErlotinib Tablet in combination with gemcitabine is indicated for the first-line treatment of patients with locally advanced, unresectable or...
Roche Tecentriq Pivotal Phase III data shows hope for cancer patients Ruchika Sharma20 May 2021 11:00 AM ISTBasel: Roche today announced interim results from the Phase III IMpower010 study, showing for the first time that treatment with Tecentriq...
AstraZeneca Pharma India gets marketing nod for cancer drug Tagrisso Ruchika Sharma11 March 2021 1:21 PM ISTOsimertinib has shown to decrease the chances of cancer spreading to the brain & other distant organs.
AstraZeneca lung cancer drug Imfinzi gets nod for new dosing regimen in EU, UK Ruchika Sharma18 Jan 2021 10:30 AM ISTNew Delhi: AstraZeneca has recently announced that the company's Imfinzi (durvalumab) has been approved in the European Union and the UK for an...
FDA approves Tabrecta for metastatic lung cancer Dr. Kamal Kant Kohli7 May 2020 3:26 AM ISTThe U.S. Food and Drug Administration has approved Tabrecta (capmatinib) for the treatment of adult patients with metastatic non-small cell lung...
Major advances seen in 'non-small cell lung cancer' treatment Meghna A Singhania3 Jan 2016 4:15 PM ISTWashington: Although the most common type of lung cancer - non-small cell lung cancer (NSCLC) - has recently seen major treatment advances in some...
Triple therapy to help fight deadly lung cancer savita thakur thakur2 Jan 2016 11:08 AM ISTWashington: In experimental models of lung cancer, researchers have found that a combination of two drugs plus radiation can help treat resistant lung...
FDA approves new oral therapy to treat ALK-positive lung cancer Pooja Bhatia Bhatia12 Dec 2015 9:29 AM ISTThe U.S. Food and Drug Administration today approved Alecensa (alectinib) to treat people with advanced (metastatic) ALK-positive non-small cell lung...
Merck's Keytruda extends survival in lung cancer study Meghna A Singhania27 Oct 2015 11:14 AM ISTMerck & Co's approved Keytruda lung cancer treatment provided superior overall survival to chemotherapy in a late-stage study of patients with...
Merck KGaA to focus on its oncology business Pooja Bhatia Bhatia13 Oct 2015 11:11 AM ISTAfter the falling business of its flagship drug Rebif, used for multiple sclerosis, Merck KGaA is now betting its fortunes on its oncology business to...
